@entity792 in @entity1 with XXXX : a comprehensive review.

@entity1 @entity5 @entity41025 @entity784 @entity1892 @entity792
BACKGROUND: Increased risk of @entity1892 in @entity1 with @entity792 is well known. Medical literature also links various autoimmune conditions with @entity784 ( @entity784 ), a rarer but very heterogeneous group of generally aggressive @entity5 . METHODS: Herein, we provide a comprehensive analysis of the available peer-reviewed literature on epidemiology, clinico-laboratory features and management of @entity792 in @entity1 with @entity41025 . Most relevant publications were identified through searching the PubMed/Medline database for articles published from inception to June 2014. FINDINGS: Prevalence of various hematologic and non-hematologic autoimmune conditions in @entity1 with @entity41025 appears to be increased. Due to the rarity of @entity41025 , scientific literature on autoimmune conditions in these @entity1 consists mainly of case series and isolated reports. CONCLUSIONS: @entity792 can develop prior to, during or after the onset of @entity41025 . The diagnosis of @entity41025 should prompt early recognition of certain @entity792 if clinical suspicion exists. A dysfunctional immune response in these @entity1 may be responsible for the occurrence of @entity792 . Conversely, autoimmune conditions might create a favorable milieu for @entity784 pathogenesis. Therefore, their presence should increase the suspicion of @entity41025 in an appropriate clinico-laboratory context. There is need for larger studies to assess further the @entity41025 - @entity792 relationship as prognosis and management of these @entity1 can be considerably affected.
